MELISSA SABARI: Open Payments
NPI 1184346835 · RIVERDALE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,870 in 139 payments from 18 companies in 2025. Trend: 2023 $1,282 · 2024 $1,867 · 2025 $1,870
Food & beverage: $1,770Education: $100
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 19 | $331 |
| ABBVIE INC. | 31 | $286 |
| Janssen Biotech, Inc. | 18 | $236 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 24 | $171 |
| Incyte Corporation | 12 | $138 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $137 |
| Amgen Inc. | 6 | $107 |
| GENZYME CORPORATION | 5 | $90 |
| ConvaTec Inc. | 4 | $75 |
| Regeneron Healthcare Solutions, Inc. | 4 | $73 |
Products named: Zoryve, TREMFYA, SKYRIZI, OPZELURA, Cabtreo, OTEZLA, DUPIXENT, ILUMYA.
Industry payments across NJ — which companies pay providers there.
